Dosage and dosage forms in herbal medicine

Published on 23/06/2015 by admin

Filed under Complementary Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 3.8 (4 votes)

This article have been viewed 10572 times

6 Dosage and dosage forms in herbal medicine

The subject of appropriate dose is probably the most controversial aspect of contemporary Western herbal medicine. Among Western herbal practitioners, many different dosage approaches are found from country to country and within countries. Underlying these different approaches are different philosophies about the therapeutic action of medicinal plants.

At one extreme is the assumption that the therapeutic effect relies on a specific dose of the active chemicals contained in each particular plant. At the other extreme, emphasis is placed on the assumption that a herbal medicine, being derived from a living organism, carries a certain energy or vital force. The quality of this energy confers the therapeutic effect and hence the amount of actual herb is not as important, as long as some is present. Others perhaps feel that the active components act as catalysts to restore health and do not need to be present in pharmacological quantities.

The low dosage approach should not be confused with homeopathy, although it has been influenced by this system. One important difference from homeopathy is that the therapeutic indications are not derived from the principle of similars and mainly come from traditional indications. Like homeopathy, this approach probably relies on a high degree of patient susceptibility to the medication.

Both the high and low dosage approaches have their adherents who maintain that their respective systems give good results in the clinic. While it is inappropriate to label one approach as correct and the other incorrect (indeed, even high doses of herbs possibly also act through other unknown interactive factors), it is useful to review and contrast current and historical dosage approaches. By doing this, one can arrive at an appropriate dosage system for modern phytotherapy in that it is consistent with:

In any discussion of herbal doses, the influence of dosage form and quality of preparations must also be considered, as should the mechanics of formulation and prescription writing.

Review of dosage approaches

Traditional Chinese medicine

The daily dose for individual non-toxic herbs in traditional Chinese medicine is usually in the range of 3 to 10 g, given as a decoction or in pill or powder form.1 Often higher doses are prescribed by decoction than for pills, as might be expected since not all active components readily dissolve in hot water.2 (Pills generally consist of the powdered herb incorporated into a suitable base.) Herbs are invariably prescribed in formulations. Doses for such formulations are about 3 to 9 g taken three times daily but can be higher in the case of decoctions.

For each individual herb, a wide dosage range is usually given in texts. (This applies for all herbal systems.) One reason for this is that if a herb is used by itself or with just a few other herbs, a larger dose is used than when it is combined with many other herbs.2 Dose also varies according to the weight and age of patients and the severity or acuteness of their condition.

Recently, a more processed form of dosage has become popular among practitioners of Chinese medicine. This involves the prescription of formulas in a granulated form. The granules are prepared by drying or freeze-drying decoctions, that is aqueous extracts, of herbal formulas. Usually 2 g of granules is prescribed three times daily, which corresponds to about 6 to 10 g of original dried herbs per dose.

Some herbs, or closely related species, are used in both Chinese and Western herbal medicine. Table 6.11,3,4 compares dosages for a few of these herbs.

Table 6.1 Comparison of dosages used in Chinese and Western herbal medicine

Herb Chinese dosage1  g/day Western dosage3,4  g/day
Ephedra sinica 3–9 3–9 (extract)
    3–12 (decoction)
Zingiber officinale 3–9 0.75–3 (decoction)
0.38–0.75 (tincture)
Taraxacum mongolicum 9–30 6–24 (decoction)
3–6 (tincture)
Glycyrrhiza uralensis 3–12 3–12 (decoction)
6–12 (extract)
Rheum palmatum 3–6 2.3–4.5 (decoction)
1.8–6 (extract)

Note: For dosages of tinctures and extracts given three times daily, the corresponding amount of dried herb per day has been calculated.

In general, the similarity in the dosage range between the different systems is striking. Discrepancies do exist for Zingiber and Taraxacum, which in the case of Zingiber can be explained by a higher content of the active components in the alcoholic tincture compared to the decoction, and, in the case of Taraxacum may be a reflection on the different species used.

Eclectic medicine

Eclectic medicine was a largely empirical school of medicine which developed in America during the 19th century.6 The movement was most prominent for a brief period from the late 19th to the early 20th centuries, when there were several teaching universities and many eminent scholars in the USA. Although the Eclectics used simple chemical medicines such as phosphoric acid, they mainly prescribed herbal medicines. Their knowledge of materia medica was their greatest contribution to Western herbal medicine; for example, herbs such as Echinacea and golden seal were made popular by them after observation of their use by the Native Americans.

The Eclectics tended to use higher doses than those recommended in current texts and pharmacopoeias, although the ranges tend to overlap. Table 6.2 compares dosages currently used3,4 with those found in Eclectic texts7,8 for alcoholic extracts of herbs.

Table 6.2 Comparison of dosages used by the Eclectics and modern dosages

Herb Eclectic dosage7,8  g/day Current dosage3,4  g/day
Euphorbia hirta 1.8–10.8 0.36–0.9
Echinacea angustifolia 0.9–5.4 0.75–3.0
Hydrastis canadensis 0.9–10.8 0.9–3.0
Passiflora incarnata 1.8–10.8 1.5–3.0
Valeriana officinalis 2.1–6.0 0.9–3.0
Rumex crispus 1.8–10.8 6.0–12.0
Viburnum opulus 3.6–10.8 6.0–12.0
Serenoa repens 2.7–10.8 1.8–4.5

Note: The corresponding amount of dried herb per day has been calculated from recommended dosages for fluid extracts.

The British Herbal Pharmacopoeia

The British Herbal Pharmacopoeia 1983 (BHP) carries extensive dosage information for individual herbs and is generally regarded as an important traditional reference on this subject for Western herbal practitioners. Dosages given in the BHP were derived from earlier texts such as the British Pharmacopoeia (BP) and the British Pharmaceutical Codex (BPC) but also resulted from a survey of herbal practitioners. More recently, the British Herbal Compendium (BHC) has been published in two volumes, with dosage information for the practitioner.9,10

The doses given by the BHP 1983 contain some inconsistencies. The main problem is that doses for tinctures often do not correlate to corresponding doses for liquid extracts. For a 1:1 extract and a 1:5 tincture of a particular herb to correlate in terms of dose, the dose range for the tincture should be five times that of the extract, since it is theoretically five times weaker. This problem contrasts with other pharmacopoeias such as the BPC 1934 where the correlation is generally, but not exactly, observed. Some examples that highlight this problem are provided in Table 6.3.

The poor correlation demonstrated in Table 6.3, where in the case of Eupatorium purpureum the tincture dose is actually less than the extract dose, probably arises for two reasons:

Since tinctures better preserve the chemical profile of the dried herb, more credibility should be given to the tincture doses when using the dosage ranges in the BHP 1983.

Commission E and ESCOP monographs

Under the direction of the German Health Department, the Commission E prepared a series of monographs on commonly used medicinal herbs during the 1980s. The Commission E was an expert committee consisting of doctors, pharmacologists, pharmacognocists and toxicologists from both academia and industry. If a herb did not receive a positive monograph from the Commission E, it could not be readily registered as a medicine in Germany. In the preparation of a monograph, the Commission E took into account relevant traditional use as well as scientific research.

A positive monograph for a herb also included dosage information. Many of the monograph doses are for infusions or decoctions since this reflects the common use of teas in the German marketplace.11 Such daily doses are usually in the range of 2 to 10 g. Occasionally a monograph will specify a dose for a herb in terms of major active constituents; for example, for Ephedra the daily dose is 45 to 90 mg of alkaloids (about 4 to 8 g of herb) which is similar to the range in Table 6.1. Occasionally, where tincture and extract doses are given by the Commission E, there is not always a good correlation. For example, the single dose for valerian tincture is 1 to 3 mL and yet the single dose for a fluid extract is 2 to 3 mL. The reasons for this may be the same as those discussed above for the BHP 1983.

The Scientific Committee of ESCOP (European Scientific Cooperative of Phytotherapy) has published a series of herbal monographs.12,13 These were compiled by an international team of expert authors and represent a major contribution to the harmonisation of standards for herbal medicines across the European Union. These monographs contain useful dosage information reflecting the European situation and have been taken into account for the dosage recommendations in this text.

The low dosage approach

Currently in the USA, New Zealand, parts of Europe (especially among homeopaths) and to some extent Australia, there are practitioners who prefer to prescribe drop doses of 1:5 or even more dilute tinctures. It is useful to examine the possible origins of this approach.

In Europe, homeopaths often use combinations of herbal mother tinctures in drop dosage, for example, ‘drainage’. This approach is sometimes incorrectly labelled as ‘phytotherapy’.

In the USA a more direct influence comes, ironically, from a development of Eclectic medicine. In 1869, the Eclectic physician John Scudder proposed the concept of ‘specific medication’.7 With this concept, medicines were matched specifically to the symptom picture of the patient and then given in the minimum dose required. Although this system may seem similar to homeopathy, there were important differences.16 Material doses were always used, albeit lower than those prescribed by other Eclectics, and the prescription was not based on the law of similars. However, like classical homeopathy, there was a tendency to use only one medicine at a time.

Scudder initially proposed that ‘specific medicines’ should be tinctures prepared from the fresh plant.16 A fresh plant tincture is sometimes still called a ‘specific tincture’. Hence, the approach of using drop doses of tinctures, especially fresh plant tinctures, also comes from Scudder.

Although Scudder’s system of specific medication was seen as an important development in Eclectic medicine, it was considerably modified by Lloyd.17 Lloyd felt that drop doses of tinctures were too low and described the preparations proposed by Scudder as ‘superficial’. Lloyd proceeded to develop elaborate herbal preparations which were concentrated, semi-purified liquids. He also called these ‘specific medicines’ and they were widely adopted by Eclectic practitioners. However, in the early 20th century English herbalists aligned themselves with the American physiomedicalists in using simpler formulations, because Lloyd’s specific medicines proved too costly to import.

Lloyd sometimes used solvents other than ethanol and water in the preparation of his specific medicines.17 His methods were kept secret and even today are not widely known. Lloyd writes: ‘The aim has been to exclude colouring matters … and inert extractive substances also from these preparations …’. In this sense, he was tending towards the concept of orthodox drugs. However, his preparations were still chemically complex and ‘very characteristic’ of the original herb.17 According to Felter, the specific medicines developed by Lloyd were at least eight times stronger than 1:5 tinctures.7 It is these highly concentrated preparations which were generally used by Eclectic physicians in drop doses, and even then doses could be quite high – up to 60 drops (3 mL) three times daily.7

In conclusion, the use of drop doses of tinctures, especially fresh plant tinctures, originated in response to the availability of more concentrated specific medications and was not representative of the general practice of Eclectic medicine, nor initially a challenge to traditional dosages.

A rational system for modern phytotherapy

The dosages used by the traditional systems of India and China, by most of the Eclectics and those established by clinical trials or recommended by expert committees or in pharmaceutical texts all tend towards the higher end of the dosage spectrum. Such an agreement should not be ignored if there is to be consistency in modern phytotherapy.

If liquid preparations are to be used, then the BHP 1983 is an appropriate guide. However, as discussed above, more credibility should be given to the tincture doses. The difficulty in using 1:5 tinctures is the large volumes which are required to achieve BHP doses for multi-herb formulations. One way to overcome this problem is to make a more concentrated preparation but without the use of heat or vacuum. Such a preparation would be more akin to a 1:5 tincture than a fluid extract, since it would better reflect the chemical characteristics of the starting herb. The most concentrated preparation which can be achieved from a dried herb without using heat or vacuum concentration, and yet achieving high extraction efficiency, is a 1:2. A process of cold percolation is necessary to achieve a 1:2 extract. Dosages for 1:2 extracts can be calculated as 0.4 of the dose for 1:5 tinctures, since they are 2.5 times stronger.

This approach enables the use of multi-herb formulations consistent with BHP and BHC dosage guidelines. For special preparations, such as herbal extracts standardised for active components, dosages established by clinical trials should be followed.

Oral dosage forms in herbal medicine

It is worth examining the relative advantages and disadvantages of the various oral dosage forms used by practitioners of Western herbal medicine.

Liquids

Liquid preparations have considerable advantages and are widely used. The main advantage is the easy preparation of formulations for each individual patient (extemporaneous dispensing). The other considerable advantage of liquids is that, if properly prepared, they involve minimal processing and truly reflect the chemical characteristics of the herb in a compact, convenient form. They also confer considerable dosage flexibility, which is especially relevant when prescribing low doses for small children. Liquids are readily absorbed and are convenient to take.

Superior bioavailability is also an under-researched advantage of herbal liquids. When a solid dosage preparation is ingested, it must first disintegrate. The plant’s phytochemicals need to dissolve in digestive juices (and the water simultaneously imbibed with the tablet or capsule) in order to be absorbed by the body. Research has demonstrated that there is a relationship between the rate and degree of dissolution of the phytochemicals in a solid dosage preparation and their ultimate absorption into the bloodstream. The advantage of herbal liquids is that the all-important phytochemical constituents are already in solution.

The main disadvantage of liquids is taste, although in the case of bitters the taste is an essential part of the therapy. The taste problem is somewhat exaggerated by some patients. Most patients get used to the taste of their mixture and some even grow to like it. If taste becomes a problem, there are flavouring preparations available and these are particularly useful for children.

It is helpful to ask patients before prescribing if they mind taking strong-tasting liquids. This will draw a commitment from those who say it is not a problem and guide the clinician to solid dose alternatives if the answer is otherwise.

The way a herbal liquid is taken can minimise the experience of any unpleasant taste. The most important factors are the contact time of the remedy in the mouth and the intensity of the contact. Some practitioners claim that absorption from the oral cavity is often part of the activity of herbal preparations. So it may in fact be preferable to prolong the contact time. But from the point of view of taste, it should be minimised.

To reduce the intensity of the contact, the herbal liquid must be diluted. However, if it is diluted too much the contact time will be too long. So there is a trade-off between intensity and contact time. It is recommended that a 5 mL dose is diluted with around 10 mL of water or fruit juice. This can easily be swallowed in one go, making the contact time minimal. Another way to reduce further the intensity of the contact is to suck on some ice beforehand. This deadens the taste buds and the olfactory nerve. Chilling the medicine beforehand and adding chilled water is another way to reduce the taste intensity.

Contact time can be further reduced by immediately rinsing the mouth with water or fruit juice. About 50 mL can be quickly consumed immediately after the liquid is taken. To best achieve this, the diluted liquid should be in one hand and the rinse in the other. They are then consumed in a one–two action, as quickly as possible. Using this technique, taste can be dramatically minimised and few patients complain of any problem. For herbs with a lingering aftertaste, eating something afterwards will help.

Another option to avoid the taste of a herbal liquid is to put the liquid (undiluted) into a hard gelatin capsule using a dropper. The capsule will soften slowly over the next hour, so it can be conveniently consumed well before this happens.

Another disadvantage of liquids that applies in a few cases is the alcohol content. This is if the patient is allergic to alcohol or is an ex-alcoholic who does not wish to take alcohol in any form. Also, some strict Muslims will also not take alcohol, even in medicines. Only a very small minority of patients are genuinely sensitive to alcohol. In others, a presumed sensitivity is only an exaggerated reflex response to the medicine. This can usually be alleviated by lower doses at greater frequency, taken with copious water or food. Usually the small quantities of alcohol involved will not affect a mildly damaged liver – a 5 mL dose contains as much alcohol as about one-sixth of a glass of beer or wine. The alcohol content of liquids is not a problem for children since correspondingly lower amounts of liquids, and hence alcohol, are prescribed.

Use of alcohol in herbal liquid preparations is important since it is a good solvent for herbal active components and an excellent preservative. This is discussed in more detail later in this chapter, together with a brief review of the history and context of ethanol use in herbal preparations.

Tablets

Herbal tablets are a convenient dosage form and no problems with taste or alcohol are associated with their use. However, tablets contain fixed formulations which cannot be exactly adapted to the needs of the individual patient. Therefore, it is critical that the herbs contained in a tablet are carefully chosen for the disorder they are intended to treat. Even then, the degree of treatment flexibility is limited.

A major potential problem with tablets is the degree of processing required. Processing is minimal for tablets containing the powdered herb, but the amount of herb which can be incorporated into such tablets is limited (without making them excessively large). Tablets are therefore usually made from extracts, which are more concentrated than the original dried herb. In order to achieve this, the herb is first extracted with a solvent. Often water is used to keep costs down. The resultant liquid is then dried to either a soft or a powdered concentrate using processes such as vacuum concentration or spray drying. Heat-sensitive or volatile components can be damaged or lost by this process. Heat is also sometimes used in the tablet-making process via a granulation step: the tablet mixture may be wetted and then dried in an oven before the final pressing. This risks further damage to the active components. Hence, when manufacturing tablets, quality may be sacrificed for the sake of quantity. One way to compensate for this problem with concentrates is to standardise each herbal ingredient for key active components. However, the components chosen for standardisation must be meaningful in terms of the desired activity of the herb (see later). In other words, they must be meaningful indicators of quality.

Another problem with tablets is that, despite the use of concentrates, they are sometimes formulated to contain low amounts of herbs. Many tablets contain herbs in equivalent dried herb doses of 1 to 50 mg (that is, the herb is there as a concentrate and the equivalent amount of dried herb is calculated from the known strength of the concentrate). It is difficult to see how therapeutic doses can be achieved from such small quantities.

For many patients one liquid formulation may not be enough to treat adequately their complex and varied medical conditions. This is where tablets can be extremely useful. For these patients a herbal formulation can be combined with one or more tablet formulations.

Sometimes only tablets can confer clinically effective doses. Some herbal products have been shown in clinical trials to be only effective at high doses. If these herbs were given in liquid form, the doses of liquid needed would be impractically high. A good example of this is the willow bark tablet that contains around 8 g of willow bark. This means that each tablet is equivalent to 16 mL of a 1:2 liquid extract. The only practical way to give such clinically effective doses of willow bark, based on clinical trials, is to use a herbal tablet.

Boswellia is a highly resinous herb which needs to be extracted in 90% alcohol. Hence, if Boswellia was used as a liquid and administered at clinically effective doses, the amount of alcohol the patient would need to consume would be too high. So the best way to give Boswellia is therefore in tablet form (or as a capsule).

By using herbal tablets, the herbalist does not need to carry an overly large range of herbal liquids in their dispensary. For example, for a condition such as a urinary tract infection, rather than carrying three or four herbs to treat this issue, only one tablet product needs to be stocked. Tablets are also far more easily transported both from the supplier and to patients in remote locations, and for use during travel.

A well-developed tablet formulation, put together by experienced and knowledgeable herbalists, represents a valuable tool, especially for the young and inexperienced practitioner. In a sense, the practitioner who uses such a formulation is drawing on the wealth of clinical experience of the formulators and is more likely to achieve a better clinical result and to learn through that process.

Powders

Sometimes the best way to prescribe a herb is as a powder. This particularly applies to mucilage-containing herbs. When these herbs are mixed with water, the mucilage reacts with the water to form a gel and the wet herb swells to many times its original volume. Mucilage is not very soluble in alcohol-water mixtures, hence it is difficult to use mucilaginous herbs effectively as liquids. In any case, if fluid extracts of, say, slippery elm and marshmallow were properly made, they would be so gelatinous that they could not be poured.

When giving mucilaginous herbs as powders it is best to advise the patient to mix them quickly with water and to take the mixture immediately before it swells. Otherwise, the patient often experiences difficulty negotiating the gelatinous mass which results. A copious amount of water should then be consumed to allow swelling in the stomach. Other herbs given as powders are also best taken slurried with water and rinsed down by additional water.

Tannin-containing herbs for the treatment of colon problems should also be given as powders. This is because the tannins are only slowly dissolved from the herb matrix and, therefore, are still being released in an active form when the powdered herb reaches the colon.

A big advantage of powders is that the total constituents of a herb are presented to the patient’s digestive tract, rather than those constituents which only dissolve in alcohol or water. This can also be a disadvantage if the patient has compromised digestion. Where the fat-soluble components are an important part of the activity of a herb, the powder should be followed by a dose of vegetable oil or lecithin to assist absorption.

The preparation of liquids

It is useful to consider in detail some of the factors involved in the preparation of herbal liquids.

The strength or ratio

The strength of a liquid preparation is usually expressed as a ratio. For example, 1:5 means that 5 mL of the final preparation is equivalent to 1 g of the dried herb from which the preparation was made. Liquid preparations weaker than 1:2 are usually called ‘tinctures’ whereas 1:1 and 1:2 preparations are typically called ‘extracts’. Tinctures are usually made by a soaking process known as maceration, whereas extracts are best made using percolation. However, tinctures can also be adequately manufactured by a percolation process. These days, 1:1 liquid extracts can be made by reconstituting soft or powdered concentrates (not recommended).

It has been argued that 1:2 extracts are relatively new, are not mentioned in the BHP 1983 or other pharmacopoeias and therefore should not be used. In fact, 1:2 extracts are mentioned in 19th century texts16,18 and were described in the German Pharmacopoeia (DAB). The seventh edition of the DAB actually defines a liquid extract as a 1:2 extract.19

The dominant historical use of 1:1 extracts may not have been the wisest choice because of the extra processing required. In 1953, a Dutch PhD student studied the impact of pharmaceutical processing on some active components of thyme (Thymus vulgaris).20 The components tested were the phenols (thymol and carvacrol), which are responsible for the antiseptic activity of thyme. Thymol and carvacrol are found in the essential (volatile) oil of thyme and could conceivably be lost under conditions of vacuum or heat. The following preparations were made:

The phenol content in all four preparations and in the original herb was measured and the results are summarised in Table 6.4. The table also provides the essential oil content of some of the preparations.

As can be seen from Table 6.4, the 1:2 extract contains only marginally less phenol content than the 1:1. This is presumably because the phenols were largely lost during the heating of the second percolate which occurs in reserved percolation. Hence, on the basis of the active components tested, the 1:2 is almost as strong as the 1:1. It should be noted from Table 6.4 that neither the 1:1 nor the 1:2 quantitatively extracted all the phenols from the dried herb, presumably because these components were not completely soluble at the ethanol percentage chosen. The 1:2 contained 37% of the original phenol content in the dried herb, compared to 22% for the 1:1.

The results for the soft and powdered extracts are disturbing. For the soft extract, 82% of the phenols were lost in processing, and for the powdered extract the loss was 48%. Compared to spray drying, conditions of vacuum therefore seem more likely to cause the loss of essential oil components, although the losses in both cases are considerable. A Swiss study found that concentration of a chamomile extract under vacuum caused the loss of about half of the essential oil.21

The content of essential oil and phenols in the corresponding amount of dried herb are also provided for the various preparations in the right-hand columns of Table 6.4. As can be seen from the table, the soft and powdered extracts only contain a fraction of the essential oil and phenol content of the dried herb. Hence, for this example, the use of these concentrates in the manufacture of liquids, tablets or capsules would clearly represent a substantial sacrifice of quality for the sake of an increase in quantity. If the soft extract was reconstituted to a 1:1 which is a common practice, it would contain about 30% of the phenol content of the 1:2 (0.04% versus 0.11%).

Ethanol-water as the solvent

Ethanol (or alcohol) has been used for hundreds of years to prepare liquid herbal preparations and indeed ethanol-water mixtures do appear to be quite efficient for the extraction of a wide variety of compounds found in medicinal plants. Chemical analyses of organic substances absorbed into pottery jars have recently confirmed the use of medicinal wines in ancient Egypt (about 3150 bc and millennia thereafter) and ancient China (seventh millennium bc). The ancient Egyptian wine contained herbs and tree resins dispensed in wine made from grapes. The jar from ancient China contained a mixed fermented beverage of rice, honey and fruit (hawthorn (Crataegus spp.) fruit and/or grape). The medicinal use of wines has been described in ancient documents, and the early Chinese history of fermented beverages is suggested from the shapes and styles of Neolithic pottery vessels.22,23 Ancient Egyptian papyri describe water, milk, oil (presumably olive oil), honey, beer and wine as carriers for medicinal herbs. Jewish medicine, described in the second-century Talmud, refers to a ‘potion of herbs’ mixed with beer or wine.24

Although the principle of distillation was known to the ancient Greeks, the Arabs adapted the process to produce alcohol, which they then used for medicinal purposes. (The word alcohol, which first appeared in most modern languages in the 16th century, was derived from Arabic (al-koh’l).)25

The first official British Pharmacopoeia, the London Pharmacopoeia, was issued in 1618. It contained a section outlining ethanolic fluid extracts and drew heavily on the classics.26

Nicholas Culpeper, the 17th century English herbalist and one of the best-known advocates of Western herbal medicine, described the distillation of one or more herbs in wine, and the maceration of spices in alcohol. Single herbs, such as dried wormwood (Artemisia absinthium), rosemary (Rosmarinus officinalis) and eyebright (Euphrasia officinalis), were steeped in wine and set in the sun for 30–40 days to make a physical wine.27

A number of studies have highlighted the importance of the correct choice of the ethanol percentage in terms of maximising the quality of liquid preparations. The Swiss study mentioned above found that 55% ethanol was the optimum percentage for the extraction of the essential oil from chamomile (Matricaria chamomilla).21 Higher percentages of ethanol did not extract any additional oil and there was a decrease in the solids content of the extract, which indicates that other components were being less efficiently extracted. More recently, Meier found that 40–60% ethanol was the optimum range for achieving the highest extraction efficiency for the active components of a variety of herbs.28 For example, at 25% ethanol, none of the saponins in ivy leaves (Hedera helix) was extracted, but at 60% ethanol they were maximally extracted.

Higher ethanol percentages do not always confer higher activity. French researchers found that Viburnum prunifolium bark extracted at 30% ethanol was five times more spasmolytic than a 60% extract.29

The basic guidelines for the choice of the ethanol percentage to optimise the activity of the final liquid are as shown in Table 6.5.

Table 6.5 Choice of ethanol percentage to optimise the activity of final liquid

Ethanol (%) Final liquid
25% Water-soluble constituents such as mucilage, tannins and some glycosides (including some flavonoids and a few saponins)
45–60% Essential oils, alkaloids, most saponins and some glycosides
90% Resins and oleoresins

Some educators have suggested that herbal liquids are a less desirable dosage form because they are less stable than solid dosage preparations. However, there is little objective evidence to back up this assertion. Some companies now undertake stability studies on their herbal liquids as a requirement of pharmaceutical GMP, and experience in this field is that most liquids maintain their phytochemical profiles within the normal shelf-life requirements of 2 to 3 years.

Provided herbal liquids are purchased through a herbal manufacturer which operates to pharmaceutical GMP standards and has a comprehensive stability programme in place, keeping to within expiry dates is sufficient to ensure retained activity. This is, of course, if the manufacturer’s recommended storage conditions are observed. Sunlight is particularly damaging to the phytochemicals in a herbal liquid, so they must be stored in amber glass bottles away from direct sunlight. Temperature is also an important factor. Generally storage below 30°C (86°F) is recommended (temperatures occasionally above 30°C (86°F) will not cause a problem, if the average is below this level). Also a minimum storage temperature of 10°C (50°F) should be maintained. Some herbal liquids such as celery and wild yam will form into a gel if they become too cold. While gentle reheating will generally make them liquid again, irreversible changes may occur if the cold conditions are prolonged.

Many herbal liquids develop a sediment over time. If the extract has not been heated during its manufacture this is a natural occurrence which generally has only a minor impact on quality. A common question among practitioners is whether this sediment should be rejected or redispersed into the liquid. There are no hard and fast rules here, but a general guide is that if the sediment has tended to aggregate or concrete into a hard mass, then it should be rejected. If, however, the sediment is fine and easily redispersed, then the bottle should be shaken to do this before dispensing. For mixtures of several herbal liquids the sediment should always be redispersed

Glycetracts or glycerites are liquid preparations made using glycerol and water instead of ethanol and water. They are useful preparations where the active components are water-soluble, for example, marshmallow root (Althaea officinalis), since they do not contain alcohol and the sweetness of the glycerol gives them a better taste. However, their importance should not be overrated. Glycerol is a poor solvent for many of the active components found in herbs and glycetracts are less stable than alcoholic extracts. Moreover, because of the viscosity of glycerol, concentrated preparations are difficult to make by percolation. The manufacture of 1:1 or 1:2 glycetracts therefore invariably requires the use of a concentration step involving heat or vacuum.

In recent times the use of tinctures made from the fresh plant has become popular among some herbalists. The belief is often that a fresh plant tincture better reflects the plant’s ‘vitality’ or ‘energy’ and therefore will be a more therapeutic preparation. Other practitioners believe that a fresh plant tincture will better preserve the delicate active components of the plant.

On the other hand, the following observations need to be considered:

• The evidence from phytochemical analysis that fresh plant tinctures contain better levels of active components than dried plant tinctures is generally lacking. In fact, fresh plant tinctures are usually prepared in a low alcohol environment (see below), which means that some less polar (more lipophilic) components may be only poorly extracted. Furthermore, the enzymatic activity of the plant material may not be inhibited in this low alcohol environment, meaning that key phytochemicals may actually be decomposed during the maceration process. This fact was dramatically illustrated by Bauer who found that cichoric acid in fresh plant preparations of Echinacea purpurea was largely decomposed by enzymatic activity.30 So what can be found in the living Echinacea plant was not preserved in the fresh plant tincture.

• Fresh plant tinctures were never official. While fresh plant preparations were included in homeopathic pharmacopoeias (given the energetic considerations in homeopathy this is understandable), they were never listed in conventional pharmacopoeias, other than a few entries for stabilised fresh juices known as succi (singular: succus). Hence, the use of a wide range of fresh plant tinctures is travel into unknown territory.

• Because of the water content of fresh plant tinctures, it is difficult to make preparations which are stronger than a 1:5 on a dry weight basis. This can be readily illustrated by the following example. A leafy, fresh plant material typically contains 80% moisture. Therefore, 100 g of this material represents 20 g of dried herb. To make a 1:5 tincture, this 20 g equivalent of dried herb must be mixed with 100 mL of liquid menstruum. But there is already 80 mL of water from the herb itself. So to preserve the 1:5 ratio only 20 mL of 96% ethanol can be added. This 20 mL of ethanol is not enough to extract the bulky 100 g of fresh plant material. But what is probably just as detrimental is that the effective ethanol percentage is only 20% (20 mL of ethanol and 80 g (or mL) of water from the fresh plant). This is too low to extract lipophilic components and barely enough to preserve the tincture. Some authors suggest the use of multiple macerations to overcome this problem, where the resultant tincture is macerated with a new batch of fresh herb, but this only makes the situation worse, diluting the alcohol to below the level that can stabilise the final tincture.

Quality versus quantity

The issues above arise because herbs are chemically complex biological drugs which need to be processed in some way and losses of activity can occur during this processing. Few of these kinds of problems arise when using pure chemicals.

But even if the problems of processing the herb are ignored, there remains the problem of the quality of the herb itself. A herb is biologically defined and even if this biological definition is adhered to (and sometimes unfortunately it is not), there is an element of chemical uncertainty. The active components of a particular dried herb can vary considerably. This is due to factors such as climate, soil conditions, genetic characteristics, time of harvest, methods of harvest and drying techniques.

One way partially to solve this problem is to use ‘organic’ and ‘wildcrafted’ herbs. By definition, these are herbs which not only have been organically grown or harvested from the wild under natural growing conditions, but have also been subjected to maximum care at all stages of harvesting and drying to ensure that quality is optimised.

A more certain way to overcome the problem of the chemical variation of herbs and herbal preparations is to quantify them for indicator or marker chemicals. In other words, the content of a particular component or group of components should always be greater than a minimum level. These components may not be solely responsible for the complete spectrum of the therapeutic effects of the herb, but rather will act as indicators of consistent quality. However, they should be meaningful indicators of quality (see below). Although more research is needed in this direction, many common herbal medicines can now be quantified for active components and the appropriate dosage range can be set accordingly.

Standardised extracts

In the context of herbs, the term ‘standardised extract’ means different things to different people. To some the concept denotes herbal products which have moved away from a time-honoured traditional basis. To them standardised extracts represent highly concentrated plant extracts (artificially so). Standardised extracts are additionally represented as resulting from processes which have preferentially selected or isolated one phytochemical (or group of phytochemicals) from the herb at the expense of others that might have importance for recognised traditional uses. Or it may be even worse: some herbalists maintain that standardised extracts are frequently adulterated with pure chemicals that are added back to the extract to give it the desired level of ‘active constituent’. Moreover, the use of standardised extracts is associated with a limited, reductionist model of herbal therapy where, like conventional drugs, one herb is prescribed for the often-symptomatic treatment of a disorder.

On the other hand, many authorities in the field maintain that standardised extracts represent the future of herbal therapy because they are a way of ensuring consistent activity of a herbal extract from batch to batch. This is particularly important for replicating clinical trials on herbs or extrapolating the results of trials to a clinical setting. Standardised extracts are promoted as being more effective and higher in quality than traditional galenical extracts and the conclusion which the consumer or practitioner might reach is that the latter have no value in modern phytotherapy.

The reality is that there are examples of so-called standardised extracts that reflect all the above positions. Hence, a meaningful understanding of the value and limitations of standardised extracts can only be achieved by reviewing them on a case-by-case basis.

Issues and terminology

Consistent activity

The aim of standardised extracts is to achieve consistent activity of a herbal product from batch to batch. Depending on the circumstances, this is not always the case. If compounds other than the chosen marker compounds (see below for definition) are important for activity and these are not also fixed at consistent levels by the manufacturing process, then a standardised extract will not achieve consistent activity.

Other simpler issues can sabotage the goal of consistent activity. For example, if the analytical method chosen is not very specific towards the desired marker compounds, then this inherent weakness in the yardstick used to measure consistent activity will result in the failure of batch-to-batch consistency. This will be the case even though the certificate of analysis of the extract will provide data to suggest the same ‘activity’ for each batch.

Although standardised extracts, done well, will ensure consistent activity, they do not necessarily guarantee potency. Potency is a biological term and in this context will relate to some pharmacological or clinical outcome. Only when a particular extract has been shown to be effective in a pharmacological model or (preferably) a clinical trial, can consistent activity be linked to guaranteed potency. Fortunately, many standardised extracts have been shown to be effective in clinical trials, and provided the various caveats above and throughout this article are met, their consistent activity can be linked to guaranteed potency (see also the discussion of phytoequivalence below).

Marker compounds or constituents

Marker compounds are characteristic phytochemicals found in a plant that are chosen to represent the standard for a standardised extract. Hence, in the case of say passionflower (Passiflora incarnata), the marker compound is often chosen to be the flavonoid isovitexin and the standardised extract of passionflower is fixed to contain a consistent level of this compound (usually a few per cent). Marker compounds are not necessarily active compounds (see below). However, if well chosen they do serve a useful function in terms of quality, such as the purposes of identification and ensuring appropriate drying, handling and extraction of the herbal starting material.

Usually to achieve a consistent level of a marker compound (or compounds) in a standardised extract, the starting herbal raw material will need to contain a minimum acceptable level. This implies consistent quality practices in terms of harvesting, drying and storage of the herb. Also, the way in which the herb is processed such as extraction conditions and choice of solvent will need to be carefully controlled. Because of this, it is likely that fixing an extract to a consistent level of marker compound(s) will also render the extract more or less consistent in terms of other phytochemical components, at least for that particular manufacturer. This aspect underpins much of the utility of standardised extracts as consistent products.

However, the difficulty arises when another manufacturer then attempts to produce the same standardised extract. Although this ‘imitation’ extract will obviously be made to contain the same level of marker compound(s), it is not necessarily true that it will be an identical extract to that produced by the original manufacturer (see the concept of phytoequivalence below).

Active compounds or constituents

Active constituents are phytochemicals that are important for a given therapeutic effect of a herbal extract. This is a highly complex issue, but one proposition is simple and clear: marker compounds are not necessarily active compounds. Hence, when Ginkgo biloba leaf standardised extract (GBE) was originally manufactured to contain 24% ginkgo flavone glycosides, there was no unequivocal evidence that these compounds conferred the various and exciting therapeutic activities that had been discovered for the extract. Later research suggested that a different group of phytochemicals, the ginkgolides and bilobalide, were more important and GBE is now standardised for these as well. But in terms of say its effects in Alzheimer’s disease, the active compounds in GBE are not known. Even if the ginkgolides and bilobalide were found to be important (this could be achieved by a clinical trial comparing two Ginkgo extracts with high and low levels of these compounds which were otherwise identical), it would be unlikely that they were the only compounds important for activity. This observation is also well illustrated by the example of St John’s wort where several of its phytochemical components have been shown to have antidepressant activity. (For more details, see the relevant monographs in this book.)

Such a dilemma supports the basic premise of herbalists that the true active component is the herbal extract itself. Nonetheless, it is also likely that an extract low in marker compounds, which from pharmacological experiments have been found to have some relevant activity, will be less likely to confer a therapeutic effect and hence be poorer quality.

This last issue underlies an important point with marker compounds: they should be chosen carefully. Preference must be given to phytochemicals that (on the basis of current knowledge) are likely to have pharmacological activity that is relevant to the proposed use of the extract. On the other hand, if a marker compound is chosen which has no known useful pharmacological activity, it should not be optimised in the extract at the expense of other phytochemicals, for example, selecting for and optimising echinacoside levels in Echinacea angustifolia at the expense of alkylamides. Where the marker compound is inactive (on current knowledge), the safest approach to take is to produce a normal galenical extract standardised to the marker.

Sometimes the great body of pharmacological and clinical evidence that we have for a herb relates only to the use of one isolated, purified constituent. Good examples are ephedrine from Ephedra and berberine from Berberis spp. Clearly, it makes sense that extracts of these herbs should be standardised to these compounds. On the other hand, the temptation to regard the herbal extracts in question as merely a carrier of this constituent should be resisted. The whole extract will confer matrix effects that might modify the activity of these compounds. Hence, ‘standardised extracts’ of say Ephedra with greater than 50% ephedrine or of Berberis spp. with greater than 50% berberine should be viewed with suspicion. They are chemical medicine, not phytotherapy.

Analytical methodology

One weakness of some standardised extracts on the market is the poor or inappropriate choice of the analytical methodology employed to measure the marker compound(s). A number is only as consistent, reliable or relevant as the technique used to measure it. This is particularly evident for standardised extracts from Ayurvedic or Chinese herbs, but is by no means confined to these.

The following examples will serve to illustrate some aspects of this issue. Boswellia serrata extract is standardised to boswellic acids which, because of their anti-inflammatory activity, are important as marker compounds. However, for the majority of extracts on the market the level of boswellic acids is determined by simple acid-base titration. This method will measure the level of any acid in the extract, so an unscrupulous manufacturer could readily add a fruit acid that would result in a false and elevated reading for boswellic acids.

Sometimes gravimetric methods are used to standardise extracts. Here the attempt is to isolate the marker compound from the extract and weigh it. However, the isolation techniques used are generally quite crude and the methodology is consequently prone to much interference. This problem is exemplified by an extract of Andrographis paniculata which was supposed to contain 10% andrographolide (determined by a gravimetric technique) but by a more accurate method was found to contain no andrographolide whatsoever. Another example is a Tribulus terrestris extract certified to contain 40% saponins (gravimetric), but which contained about 4% when a more accurate analytical technique was applied.

Even the popular St John’s wort standardised extract is not free of this problem. The determination of ‘total hypericin’ is usually based on a method from the DAC (German Pharmaceutical Codex). But there are two methods found in different editions of the DAC. The earlier method will give a number for total hypericin that is about 25% higher than the later, preferred method. However, some manufacturers intentionally base the level of ‘total hypericin’ in their St John’s wort extract on the earlier, outdated method in order to inflate the value. Both these methods give a higher level of total hypericin than that obtained by HPLC (high performance liquid chromatography).

Types of standardised extracts

Based on how they are made, standardised extracts can be classified into three basic types. These are:

These types of extracts progressively represent a transition from a more traditional herbal product through to more modern types of products, which can be called phytopharmaceuticals. Phytopharmaceuticals are not like conventional drugs, but they are also very different from galenical extracts. Practitioners will wish to choose, based on their philosophical perspective, whether the use of phytopharmaceuticals is acceptable to them. However, as part of this process they should consider that phytopharmaceuticals are often chemically complex (an important criterion for phytotherapy), clinically proven and very safe. Probably, as suggested earlier, the decision is best based on a case-by-case basis.

A mechanism for formulating liquids

There are a number of mechanisms for writing liquid prescriptions but a simple system widely used in the UK is worth describing. This is the system of formulating in terms of weekly doses.

If the dose for a herb is 1 to 2 mL three times daily, then the weekly dose is 21 times this or 21 to 42 mL per week, which is usually rounded down to 20 to 40 mL. Prescriptions for patients are then written in terms of weekly doses.

Assuming the patient is to take 5 mL of a liquid formulation three times daily, this amounts to 105 mL per week which can be rounded down to 100 mL. Hence the weekly dosages of the individual herbs in a formulation should total 100 mL. If the total amount of herbs in a formula is less than 100 mL, water or aqueous ethanol can be added to bring the volume to 100 mL. Using this system the patient then automatically receives the correct amount of each herb in each dose, provided they take 5 mL three times a day (see Table 6.6).

When dispensing for more than 1 week, the weekly doses are simply multiplied by the number of required weeks. This system confers considerable flexibility and ease in prescription writing and dispensing.

Even using 1:1 and 1:2 extracts, formulations based on 100 mL for 1 week should not contain more than about six to seven herbs. Otherwise, therapeutic doses will not be achieved. If more than this number of herbs is required then the week’s formulation should be based on 150 mL. The single dose becomes 7.5 mL (which can be rounded up to 8 mL) three times daily.

References

1. Bensky D, Gamble A. Chinese Herbal Medicine Materia Medica. Seattle: Eastland Press, 1986.

2. Yanchi L, The Essential Book of Traditional Chinese Medicine. Volume 2:, Clinical practice, New York, Columbia University Press, 1995.

3. British Herbal Pharmacopoeia. Bournemouth: British Herbal Medicine Association; 1983.

4. British Pharmaceutical Codex. London: Pharmaceutical Press; 1934.

5. Nadkarni KM, Nadkarni AK. Indian Materia Medica. Bombay: Popular Prakashan Private Ltd, 1976.

6. Griggs B. Green Pharmacy. London: Jill Norman and Hobhouse, 1981.

7. Felter HW. The Eclectic Materia Medica, Pharmacology and Therapeutics. Portland: First published Cincinnati, Ohio, 1922. Reprinted by Eclectic Medical Publications; 1983.

8. Felter HW, Lloyd JU. King’s American Dispensatory, 18th ed. Portland: Reprinted by Eclectic Medical Publications, 1983.

9. British Herbal Medicine Association. British Herbal Compendium. Bournemouth: BHMA. 1992. p. 1.

10. British Herbal Medicine Association. British Herbal Compendium. Bournemouth: BHMA; 2006. p. 2.

11. Eberwein E, Vogel G. Arzneipflanzen in der Phytotherapie. Bonn: Kooperation Phytopharmaka, 1990.

12. Scientific Committee of ESCOP (European Scientific Cooperative on Phytotherapy). ESCOP Monographs, 2nd ed. UK: ESCOP Secretariat; 2003.

13. Scientific Committee of ESCOP (European Scientific Cooperative on Phytotherapy). ESCOP Monographs, 2nd ed. Supplement. UK: ESCOP Secretariat; 2009.

14. De Feudis FV. Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications. Paris: Elsevier, 1991.

15. Ravanelli OV, Haase W. Zur Wirksamkeit von Silymarin bei Leberkrankheiten. Z Prakt Anasth Wiederbelebung. 1976;30(355):1592–1612.

16. Scudder JM. Specific Medication and Specific Medicines. Cincinnati: Scudder Bros Co., 1913.

17. Ellingwood F. American Materia Medica, Therapeutics and Pharmacognosy. Portland: Reprinted by Eclectic Medical Publications, 1983.

18. Lyle TJ. Physio-Medical Therapeutics, Materia Medica and Pharmacy. London: Originally published Ohio, 1897. Reprinted by The National Association of Medical Herbalists; 1932.

19. Deutsches Arzneibuch der BRD, 7 Ausgabe; 1968.

20. Van Es MJ. Some Applications of the Spray-Dryer in Galenical Pharmacy. PhD Thesis. Utrecht University; 1953.

21. Munzel K, Huber K. Extraction procedures in the preparation of chamomile fluid extract. Pharm Acta Helv. 1961;36:194–204.

22. McGovern PE, Mirzoian A, Hall GR. Ancient Egyptian herbal wines. Proc Natl Acad Sci USA. 2009;106(18):7361–7366.

23. McGovern PE, Zhang J, Tang J, et al. Fermented beverages of pre- and proto-historic China. Proc Natl Acad Sci USA. 2004;101(51):17593–17598.

24. Bellamy D, Pfister A. World Medicine: Plants, Patients and People. Oxford: Blackwell, 1992.

25. Reuben A. Wine hath drowned more men than the sea. Hepatology. 2002;36(2):516–518.

26. Brockbank W. Sovereign remedies: a critical depreciation of the 17th-century London pharmacopoeia. Med Hist. 1964;8:1–14.

27. Tobyn G. Culpeper’s Medicine: A Practice of Western Holistic Medicine. Shaftesbury: Element Books, 1997.

28. Meier B. The extraction strength of ethanol/water mixtures commonly used for the processing of herbal drugs. Planta Med. 1991;57(suppl 2):A26.

29. Balansard G, Chausse D, Boukef K, et al. Selection criteria for a Viburnum extract, Viburnum prunifolium L., as a function of its veino-tonic and spasmolytic action. Plantes Med Phytother. 1983;17(3):123–132.

30. Bauer R, Remiger P, Jurcic K, et al. Beeinflussung der phagozytose-aktivität durch Echinacea-extrakte. Z Phytother. 1989;10:43–48.